Evidence map›Paper›PMID 28428266›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2017

KCa1.1 channels regulate β

Mark R Tanner, Michael W Pennington, Teresina Laragione, Pércio S Gulko, Christine Beeton

Open access · bronzeAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. CaInternational journal of molecular sciences · 2023
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Nephrin Signaling Results in IntegrinJournal of the American Society of Nephrology : JASN · 2019
    Article
  12. Article
  13. Article
  14. Review
  15. KCa1.1 channels as therapeutic targets for rheumatoid arthritis.Expert opinion on therapeutic targets · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Mark R TannerDepartment of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, Texas, USA.
Michael W PenningtonPeptides International, Inc., Louisville, Kentucky, USA.
Teresina LaragioneDivision of Rheumatology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Pércio S GulkoDivision of Rheumatology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Christine BeetonDepartment of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, Texas, USA; beeton@bcm.edu.
Baylor College of Medicine · USIcahn School of Medicine at Mount Sinai · USPeptides International (United States) · US

Funding

Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI Michael M Ittmann · 2007 to 2026
$73.9M
Virology CoreP30AI036211 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI KLINE, MARK W. · 1994 to 2015
$21.7M
Immunology Scientist Training ProgramT32AI053831 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI CORRY, DAVID B · 2003 to 2018
$4.2M
Training Program in Translational Biology and Molecular MedicineT32GM088129 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI ROONEY, CLIONA M., VAN DEN VEYVER, IGNATIA B · 2010 to 2019
$3.0M
BD Biosciences Special Order LSRIIS10RR024574 · NCRR · BAYLOR COLLEGE OF MEDICINE · PI LUMPKIN, ELLEN A · 2009 to 2009
$430k
Regulation of cellular interactions by potassium channels in RAF31AR069960 · NIAMS · BAYLOR COLLEGE OF MEDICINE · PI TANNER, MARK R · 2016 to 2017
$76k
NCI NIH HHS P30 CA125123NCRR NIH HHS S10 RR024574NIAID NIH HHS P30 AI036211NIAID NIH HHS T32 AI053831NIAMS NIH HHS F31 AR069960NIGMS NIH HHS T32 GM088129
6 · The paper itself

Abstract

Large-conductance calcium-activated potassium channel (KCa1.1; BK, Slo1, MaxiK,

Indexed as

Arthritis, RheumatoidCalciumCell AdhesionGene Expression RegulationHumansIntegrin beta1Large-Conductance Calcium-Activated Potassium Channel alpha SubunitsProto-Oncogene Proteins c-aktSynoviocytesCalciumIntegrin beta1KCNMA1 protein, humanLarge-Conductance Calcium-Activated Potassium Channel alpha SubunitsProto-Oncogene Proteins c-aktinvasionmigrationsynovial fibroblast

Identifiers

PMID28428266
PMCPMC5503717
OpenAlexW2606454697

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.